Predicting toxicity-related Docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer using open phase 3 trial data
Year: 2020
Type: article
Source: European Urology Open Science
Authors: A. Martini, A.B. Parikh, G. Gandaglia, N. Fossati, G. Fallara, F. Barletta, S. Scuderi, D. Robesti, D. Cannoletta, R. Leni, V. Cucchiara, C.A. Bravi, E. Mazzone, G. Rosiello, G. Basile, L. Nocera, A. Necchi, M. Moschini, J.P. Sfakianos, M.D. Galsky, W.K. Oh, C. Tsao, F. Montorsi, A. Briganti
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,800
OpenAlex ID: W3111090680